Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy.
about
Alternative RNA splicing: contribution to pain and potential therapeutic strategyMolecular signaling involving intrinsically disordered proteins in prostate cancerAberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast CancerSAM68: Signal Transduction and RNA Metabolism in Human CancerSplicing Regulators and Their Roles in Cancer Biology and TherapyCirculating RNAs as new biomarkers for detecting pancreatic cancerWrecked regulation of intrinsically disordered proteins in diseases: pathogenicity of deregulated regulatorsMicrobial and Natural Metabolites That Inhibit Splicing: A Powerful Alternative for Cancer TreatmentA case of cervical cancer expressed three mRNA variant of Hyaluronan-mediated motility receptor.Evolving Lessons on the Complex Role of AMPK in Normal Physiology and Cancer.The landscape of alternative splicing in cervical squamous cell carcinoma.Unique expression features of cancer-type organic anion transporting polypeptide 1B3 mRNA expression in human colon and lung cancers.Splicing factor SRSF1 negatively regulates alternative splicing of MDM2 under damage.Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases.Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinomaDose-Dependent Regulation of Alternative Splicing by MBNL Proteins Reveals Biomarkers for Myotonic DystrophyIdentification of a Novel Human E-Cadherin Splice Variant and Assessment of Its Effects Upon EMT-Related Events.Differential expression of alternatively spliced transcripts related to energy metabolism in colorectal cancer.Transcriptome-wide analysis of alternative RNA splicing events in Epstein-Barr virus-associated gastric carcinomasDNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patientsRelevance of splicing on tumor-released exosome landscape: implications in cancer therapeutics.Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance.Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells.Protein Sam68 regulates the alternative splicing of survivin DEx3.New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies.Alternative splicing: the pledge, the turn, and the prestige : The key role of alternative splicing in human biological systems.New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia.The CRISPR/Cas system inhibited the pro-oncogenic effects of alternatively spliced fibronectin extra domain A via editing the genome in salivary adenoid cystic carcinoma cells.Metadherin exon 11 skipping variant enhances metastatic spread of ovarian cancer.Mesenchymal stem cell contact promotes CCN1 splicing and transcription in myeloma cellsEMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression.Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers.Detection of recurrent alternative splicing switches in tumor samples reveals novel signatures of cancerATRA modulates mechanical activation of TGF-β by pancreatic stellate cells.Moringa oleifera Gold Nanoparticles Modulate Oncogenes, Tumor Suppressor Genes, and Caspase-9 Splice Variants in A549 Cells.Upregulation of the alternative splicing factor NOVA2 in colorectal cancer vasculatureAberrant expression of alternative isoforms of transcription factors in hepatocellular carcinoma
P2860
Q26744085-FB958221-8E92-4F88-BF46-F16185E80D47Q26747089-5BEEE67D-0E44-41F4-879A-15642527D748Q26773907-7159CC77-5B09-48C1-B833-C8B85D62ED31Q26798149-83277BFC-8873-42F2-9521-20535251DDC8Q26798158-90756D7C-9242-4B03-AACA-847A6C111C72Q26801191-EBCCD26B-1372-4019-A568-E70DED0FCF9DQ27000495-2B55BC82-4B6D-4504-AB6C-EE39AEC0394AQ28074931-1022EEA1-97F1-4C87-8079-27F0779912A2Q33802642-24638EB3-DF2A-401A-AB94-A7C0B042A77AQ34506762-50C4B372-D2B2-431F-85F4-C8F26720E455Q34783624-2AEEC9DF-5675-427B-9AE9-4A6EF0305D90Q34983690-23907694-A89D-4F25-AFED-F4C0F26D954AQ35562067-AC78FB52-95EC-45C3-A349-13387FD304B2Q36113481-07664D6D-B579-4E87-988A-EDE4BA2A561BQ36114523-E8273690-C37C-4996-AEAA-86A5B5251D4EQ36146964-A71FA94A-57CC-4862-A5A9-A71ADCA7ABC3Q36147466-7BC9D16C-430A-41F9-88A5-865CD09692F8Q36254983-E3A4043B-976D-4EA2-808F-8F21E26FFC10Q36368952-68F68D08-E447-49B5-AD86-86E37C1B8C2DQ37285274-983F10BF-4E6F-4E04-88B7-A72F40BB4E06Q38271955-617F319B-003A-493C-A45F-139B9993394EQ38286217-2DCC0A15-1BAC-4CEB-AE62-900BF9603BBCQ38297287-26EED985-2DFB-44CD-9B1F-E38DF8D670B4Q38698809-75B0735F-3052-4A8A-BD66-894164C7B971Q38714354-0B163043-7509-4F3A-9C39-93D3E9BFC379Q38735423-86DFDC89-6C76-44AC-BDC4-866651870CE3Q38810768-28A39DCD-ADB7-4CED-A267-61F8F82F6E03Q38909254-95A9F2AD-1325-43B8-912E-A398774AADBDQ38944987-8DFCE5F6-3084-4730-8BF2-D3F381A5454EQ38981228-4E49C000-796A-4C23-9A9C-464DCBE9C1F6Q39109931-98C26AC0-EDD1-4172-927C-780DA8797079Q39426973-5B282884-6E4D-4263-9C26-E6BEA3A3788FQ41595455-CDA15415-2126-4B29-824D-0C1D65C0F0ACQ42125567-98B6468D-489F-4956-8162-1C8BFF785248Q50428851-191AEEE1-E03F-49C7-B580-A63A6A7738D9Q57072218-68F48F9C-F3D6-4C76-A096-73CE9DCF1C89Q58603892-33A06BAB-CFB1-4296-9CCC-A90D39419078
P2860
Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oncogenic alternative splicing ...... ion and prospects for therapy.
@en
Oncogenic alternative splicing ...... ion and prospects for therapy.
@nl
type
label
Oncogenic alternative splicing ...... ion and prospects for therapy.
@en
Oncogenic alternative splicing ...... ion and prospects for therapy.
@nl
prefLabel
Oncogenic alternative splicing ...... ion and prospects for therapy.
@en
Oncogenic alternative splicing ...... ion and prospects for therapy.
@nl
P2093
P2860
P356
P1476
Oncogenic alternative splicing ...... sion and prospects for therapy
@en
P2093
Daniela Pignataro
Morena Catillo
Serena Bonomi
Stefania Gallo
P2860
P304
P356
10.1155/2013/962038
P577
2013-10-27T00:00:00Z